Browsing by Author "Aleksić, Dejan (56893486100)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Basophilic peripheral nerve inclusions in a patient with L144F SOD1 amyotrophic lateral sclerosis; [Bazofilne inkluzije u perifernom nervu kod bolesnika sa L144F SOD1 amiotrofičnom lateralnom sklerozom](2023) ;Aleksić, Dejan (56893486100) ;Perić, Stojan (35750481700) ;Milenković, Sanja (57220419015) ;Janković, Milena (54881096000) ;Rakočević-Stojanović, Vidosava (6603893359)Stević, Zorica (57204495472)Introduction. Histopathological findings of various inclusions were reported in the central nervous system of amyotrophic lateral sclerosis (ALS) patients but not in the peripheral nerves. Case report. We present a 66-year-old man with lower limb weakness, with later development of weakness in the upper limbs and loss of sphincter control. Neurological examination showed the affection of both upper and lower motor neurons. He had paresthesia on the left side of his body and socks-distribution numbness. Histopathology of the sural nerve and genetic report showed basophilic periodic acid-Schiff (PAS)-positive intra-axonal inclusions and heterozygous L144F mutation in the exon 5 of the SOD1 gene. Conclusion. It seems that the presence of the basophilic peripheral nerve inclusions may suggest a diagnosis of SOD1-positive ALS. © 2023 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Family history of disease and risk of glioma occurrence: Results of the case-control study(2020) ;Arsić, Ana Azanjac (8428022000) ;Tončev, Gordana (6506651230) ;Drakulić, Svetlana Miletić (36623676800) ;Vesić, Katarina (55873795900) ;Aleksić, Dejan (56893486100) ;Marić, Gorica (56433592800)Pekmezović, Tatjana (7003989932)Background/Aim. Malignant gliomas represent a heterogenaus group of tumors. They occur in all age groups, predominatly in males in older age. The purpose of this case-control study was to examine the association between risk for developing glioma and family history of diseases. Methods. The case-control study included 100 pathologically confirmed cases of glioma at the Clinical Centre Kragujevac, Serbia, between 2015 and 2016, and 200 age- and sex-matched controls without glioma and other malignant diseases in personal and family history at the same institution. After signing the informed consent all the patients filled out an epidemiological questionnaire. Multivariate logistic regression analysies was used in statistical data processing. Results. Malignant diseases in family history were more common in the study group than in the control group [odds ratio (OR) = 1.821, 95% confidence interval (CI) 1.004–3.305; p = 0.049]. The most common malignant tumor in the study group were cancer of the uterus (7%) and colon cancer (6%), while in the control group the most common cancer were lung cancer (6%) and cancer of the uterus (7%). Diabetes mellitus in family history was more common among control individuals than among glioma patients (OR = 0.520, 95% CI = 0.271–0.995; p = 0.048). Also, our results showed that cardiovascular diseases in family history were more common in the control group than among patients of the study group (OR = 0.557, 95% CI = 0.325–0.953; p = 0.033). Conclusion. In this case-control study, we observed a statistically significant relation between family history of malignant diseases and glioma. Also, we found statistically significant inverse relation between family history of cardiovascular diseases and diabetes and glioma. © 2020 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS; [VALIDACIJA KRATKE MEĐUNARODNE KOGNITIVNE PROCJENE MULTIPLE SKLEROZE U VELIKOJ KOHORTI BOLESNIKA S RELAPSNO-REMITENTNOM MULTIPLOM SKLEROZOM](2022) ;Drulović, Jelena (55886929900) ;Tončev, Gordana (6506651230) ;Nadj, Čongor (6507608134) ;Obradović, Dragana (7005065235) ;Eraković, Jevto (57192306386) ;Mesaroš, Šarlota (7004307592) ;Čukić, Mirjana (55891936800) ;Aleksić, Dejan (56893486100) ;Andabaka, Marko (57207949404) ;Ivanović, Jovana (57196371316) ;Jovanović, Aleksa (57216047949) ;Kostić, Marina (57812840500) ;Marić, Gorica (56433592800) ;Marković, Aleksandar (57813232900) ;Martinović, Vanja (56925159700) ;Parojčić, Aleksandra (55266544000) ;Perić, Stojan (35750481700) ;Sakalaš, Lorand (56156559400) ;Suknjaja, Vesna (35727065400) ;Vesić, Katarina (55873795900) ;Vojvodić, Sofija (57812055000) ;Vuković, Tijana (57812840600) ;Benedict, Ralph H. B. (7102333960)Pekmezović, Tatjana (7003989932)Cognitive impairment is one of the most frequently reported symptoms in persons with multiple sclerosis (MS). The Brief International Cognitive Assessment for Multiple Sclerosis (BI-CAMS) has been recommended as a standardized international screening and monitoring tool for brief cognitive assessment.The aim of our study was to assess the reliability and validity of the Serbian version of the BICAMS. A total of 500 relapsing-remitting MS (RRMS) patients and 69 age-, gender-and educa-tion-matched healthy control (HC) subjects were examined. All participants performed the BICAMS test battery, which includes the oral version of the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test second edition (CVLT-II), and Brief Visuospatial Memory Test Revised (BVMTR). A ran-domly selected subset of patients were retested one to three weeks after baseline. Statistically significant dif-ferences between patients and HCs were evident on the SDMT and BVMTR (p<0.001). HCs had higher CVLT-II scores but this difference did not reach statistical significance (p=0.063). Cognitive impairment, defined as an abnormal test score on ≥1 subtest, was found in 62.9% of MS patients.There were statistically significant correlations between BICAMS scores and age, education, EDSS and disease duration in patient sample. Test-retest reliability was confirmed with Pearson correlation coefficient of 0.70 in all measures. This study supported the reliability and validity of the Serbian BICAMS, although the CVLT-II version tested here lacked sensitivity to detect MS compared to healthy volunteers. © 2022, Dr. Mladen Stojanovic University Hospital. All rights reserved.